RTW INVESTMENTS, LP
Q3 2020 13F-HR Holdings
Net value change ($000)
+598,839
(16.8%)
New positions
22
Sold out positions
9
Turnover %
12.8%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| IMVT | 125,078 | 89.8% |
| Mirati Therapeutics, Inc. | 57,806 | 46.5% |
| ILMN | 54,089 | NEW |
| GH | 52,480 | NEW |
| NTRA | 47,344 | 62.1% |
| LONA | 45,372 | NEW |
| CYTK | 40,702 | NEW |
| MyoKardia, Inc. | 37,206 | 41.1% |
| STOK | 34,238 | 40.5% |
| RCKT | 32,449 | 9.2% |
Top Reduces (Value $000, Stocks/ETFs)
| ADVM | -67,258 | -47.4% |
| BELLUS Health Inc. | -52,003 | -84.5% |
| Dicerna Pharmaceuticals Inc | -51,663 | -28.4% |
| QTTB | -39,168 | -59.2% |
| WAVE LIFE SCIENCES LTD | -24,885 | -100.0% |
| STAA | -19,010 | -100.0% |
| AXSM | -17,392 | -12.7% |
| AVDL | -15,829 | -36.9% |
| Translate Bio, Inc. | -15,636 | -23.5% |
| OYST | -14,529 | -26.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|